Wendy Levin
Hematologist Oncologist CMO
Based in San Diego
About
Results focused Hematologist-Oncologist and Biotech executive with 15+ years of leadership advancing oncology, hematology and diagnostic assets from discovery through global registration. Provide strategic and executional support for private pre-IPO start-ups to Fortune 500 publicly traded companies and Venture Capital/Investment firms. From large pharma to innovative startups, I have served as Chief Medical Officer, and Global Clinical Lead for transformative therapies and diagnostics, leading cross-functional teams, securing over $300 million in capital, and bringing novel therapeutics and practice-changing diagnostics to market. Personal career highlights include co-authoring the first two publications on HER-2/neu (Herceptin) as an undergraduate at the University of California Los Angeles (UCLA); and serving as the Global Clinical Lead for the Pfizer SMO inhibitor Daurismo, from pre-IND first-in-human studies to designing the registration trial for acute myeloid leukemia (AML), which gained FDA approval in 2018. I most recently served as the Chief Clinical Officer of SAGA Diagnostics (an MRD platform), which was acquired by Roche/FMI in June 2026. I was named by DeciBio as one of the 2026 Women of Precision Medicine.
Looking to connect with
founders and investors in my field
Hobbies & interests
hiking, animals, love what I do for a living!
Wendy's host profiles
Experience
- Team Member at ATT
- Team Member at WJ Levin Consulting
Interests & expertise
Functions: Product
Roles: Business Owner, Consultant, Executive, Service Provider, Professional
Industries: AgeTech, BioTech, Femme Tech, Life Science, MedTech, Real Estate, Sustainability, Energy